Dongsung Pharmaceutical Co. Ltd. (KOSE:A002210) announced a private placement of 30th unregistered unsecured coupon unguaranteed private convertible bonds for gross proceeds of KRW 10,000,000,000 on July 11, 2016. The bonds will be issued at its par value. The transaction will include participation from new investors, Synergy Partners Co., Ltd., GB Synergy Mezzanine Private Fund and GB Synergy Mezzanine Specialty Investment Private Fund, funds managed by Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., and NH Investment & Securities Co., Ltd. for KRW 4,300,000,000, KRW 2,200,000,000, KRW 1,500,000,000, KRW 1,000,000,000, and KRW 1,000,000,000. The bonds will not carry any interest or any annual coupon. The bonds will mature on July 12, 2021. The bonds will be fully convertible into registered common shares of the company at a conversion price of KRW 6,073 per share. The conversion period of the bonds will be from July 12, 2017 to June 12, 2021. The payment date for the bonds is expected on July 12, 2016. The transaction was approved by the board of directors of the company.